Posts

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military. With a FY2018 budget of over $975 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer, Parkinson’s, and Multiple Sclerosis as well as additional Peer Reviewed topics covering Alzheimer’s, Cancer, and others.

In this webinar, we discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.

 

View Slide Deck

 

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle, from basic research, through pre-clinical activities and early phase clinical trials.

In this webinar, we discuss key cancer related opportunities, focusing on the new set of solicitations from the National Cancer Institute (NCI) and the soon to be released CDMRPs (DoD) that are available for life science organizations.

 

View Slide Deck

Non-US applicants are eligible for the majority of the non-dilutive pockets of money including NIH, Department of Defense, BARDA etc. Currently, the National Institutes of Health (NIH) are actively funding over 1000 projects in the excess of $1.3B, taking place outside the US and awarded to non-US applicant organizations. And, when taking into account collaborations and partnerships between domestic and foreign entities, the funded R&D dollars outside the US even exceed the above.

In this presentation, we provide insight into the non-dilutive funding landscape with an emphasis on the NIH, Department of Defense and other government agencies. FreeMind experts will describe the various pockets of money available for non-US applicants, potential for funding, and means to maximize chances for award.

View Slide Deck

In order to maximize your funding potential, all sources of funding must be considered, including the less traditional ones.

The NIH’s R21 mechanism aims to fund very early stage proof of concept type programs of up to 2 years at about $300,000, whereas the R01 mechanism is more suitable for longer programs of up to 5 years, totaling close to $3,000,000. Other agencies such as the Department of Defense, BARDA, FDA, and NSF also have awards for research in the life sciences.

In this webinar, we share insight into alternatives to the classic SBIR/STTR mechanisms. We will discuss methodology for establishing both responsiveness as well as competitiveness and how to increase chances for award.

View Slide Deck

Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences.

Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from the DOD.

In this webinar, we discuss the process for applying, guidelines, key success components and insight into increasing chances for award.

 

View Slide Deck

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military.

With a FY2016 budget of over $800 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer and Multiple Sclerosis. There are several additional Peer Reviewed topics such as Alzheimer’s and Cancer, and others.

In this webinar we discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.

View the webinar slide deck
To discuss the CDMRPs or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!